Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3976814
Max Phase: Preclinical
Molecular Formula: C13H20O
Molecular Weight: 192.30
Molecule Type: Small molecule
Associated Items:
ID: ALA3976814
Max Phase: Preclinical
Molecular Formula: C13H20O
Molecular Weight: 192.30
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCC/C=C1/C(=O)C=CC1C
Standard InChI: InChI=1S/C13H20O/c1-3-4-5-6-7-8-12-11(2)9-10-13(12)14/h8-11H,3-7H2,1-2H3/b12-8+
Standard InChI Key: ONOIGTHIWSJUJH-XYOKQWHBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 192.30 | Molecular Weight (Monoisotopic): 192.1514 | AlogP: 3.66 | #Rotatable Bonds: 5 |
Polar Surface Area: 17.07 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 1 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.39 | CX LogD: 4.39 |
Aromatic Rings: 0 | Heavy Atoms: 14 | QED Weighted: 0.48 | Np Likeness Score: 2.11 |
1. (2004) Cyclopentanone and cyclopentanone derivatives as potent activators of HSF-1, |
Source(1):